Proteasome inhibitor treatment of antibody-mediated allograft rejection

Proteasome Inhibition with Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis

(2011) A. M. Gomez et al.   JOURNAL OF IMMUNOLOGY

Early and Late Acute Antibody-Mediated Rejection Differ Immunologically and in Response to Proteasome Inhibition

(2011) R. Carlin Walsh et al.   TRANSPLANTATION

Bortezomib as the Sole Post-Renal Transplantation Desensitization Agent Does Not Decrease Donor-Specific Anti-HLA Antibodies

(2010) R. Sberro-Soussan et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Development of novel therapies for MG: Studies in animal models

(2010) M. C. Souroujon et al.   AUTOIMMUNITY

The Early Marginal Zone B Cell-Initiated T-Independent Type 2 Response Resists the Proteasome Inhibitor Bortezomib

(2010) V. R. Lang et al.   JOURNAL OF IMMUNOLOGY

Bortezomib and sirolimus inhibit the chronic active antibody-mediated rejection in experimental renal transplantation in the rat

(2010) R. Vogelbacher et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Protective Immunity Remains Intact After Antibody Removal by Means of Proteasome Inhibition

(2010) Matthew J. Everly et al.   TRANSPLANTATION

Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection

(2010) R Carlin Walsh et al.   TRANSPLANTATION

The Role of Proteasome Inhibition With Bortezomib in the Treatment of Antibody-Mediated Rejection After Kidney-Only or Kidney-Combined Organ Transplantation

(2010) Stuart M. Flechner et al.   TRANSPLANTATION

Keyword Index

(2009)   AMERICAN JOURNAL OF TRANSPLANTATION

Acute Humoral Rejection in a Lung Recipient: Reversion With Bortezomib

(2009) Jorge Neumann et al.   TRANSPLANTATION

Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production

(2008) D. K. Perry et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

(2008) Matthew J. Everly et al.   TRANSPLANTATION